European Archives - Page 386 of 1143 - European Medical Journal

Anatomical Variant of the Right Upper Lobe Bronchus

The authors present a case of a 77-year-old female, a former smoker with a history of chronic obstructive pulmonary disease who underwent…

Dr Andreas Konieczny on leading with authenticity

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.

Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny

In this episode of GOLD podcast, the latest catalyst ImmunoGen’s Andreas Konieczny offers insights on driving drug launches and leadership skills. Listen now!

A podcast exploring the DaBlaCa-13 study, chemoresection with dose-dense mitomycin C (MMC) in patients with recurrent non-muscle-invasive bladder cancer (intermediate-risk)

Tune in for a fascinating discussion with Jørgen Bjerggaard Jensen, as he explores recent breakthroughs in non-muscle-invasive bladder cancer management through mitomycin C (MMC) chemoresection.

Inflammatory-Related Diseases an Early Sign of Type 2 Diabetes?

The present study assessed the clinical histories of pre- and post-Type 2 Diabetes diagnoses with the aim of gaining insight into causes and trajectories for health-related conditions, such as cardiovascular and pulmonary disorders.

Sudden Cardiac Arrest in Patients with Type 2 Diabetes

New research has identified a range of characteristics associated with an increased risk of sudden cardiac arrest in patients with Type 2 diabetes. However, it remains difficult to predict, especially in those without a history of cardiovascular disease.

Navigating the Complexities of Metastatic Colorectal Cancer: From Genetic Mutations to Targeted Therapies

Two experts in medical oncology explore the latest developments in metastatic colorectal cancer in this episode of the EMJ podcast.

Does a History of Cancer Increase Hearing Loss Risk?

According to research, the risk of hearing loss is greater in individuals who are survivors of cancer. This is due to age and the effects of previous chemotherapy and radiotherapy. Read more.

Lung Cancer: Disparities in Incidence Rates

Incidence rates for lung cancer in US females aged 35-54 were higher than in males and older females, according to research by Ahmedin Jemal, American Cancer Society, Atlanta, Georgia, USA, and colleagues.

Healthcare Inequalities and the Exposome

Michelle Kelly-Irving joins Jonathan to speak about social, economic, and gender inequalities in healthcare, as well as the exposome.